Biograil ApS: Financial statements 2021
CVR: 40666699
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Biograil ApS (CVR 40666699) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -5,373,412 and a net result of DKK -7,932,078. Equity in the 2021 report amounted to DKK 31,938,988. The solvency ratio was 96.6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -5,373,412
- Profit/Loss
- DKK -7,932,078
- Equity
- DKK 31,938,988
- Total Assets
- DKK 33,056,023
- Employees
- 3
Official annual report
Find more companies like Biograil ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Biograil ApS has published its interim report for the period July 17, 2019 to December 31, 2020.
About Biograil ApS
Biograil ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Karsten Lindhardt. The board consists of John Michael Barberich (chair), Karsten Lindhardt, Lars Hellerung Christiansen and Robert Samuel. The company's owners include Lindhardt Holdings ApS, MTI Biograil Invest A/S and Eli Lilly and Company. The company has 23 employees (2026). In 2025, the company reported a gross profit of DKK -13,192,351 and a net result of DKK -22,366,605 compared with DKK -17,084,308 the year before. Equity in the 2025 report amounted to DKK 102,217,548.